Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Financial Statements Detail (Tables)

v3.21.2
Condensed Consolidated Financial Statements Detail (Tables)
6 Months Ended
Jun. 30, 2021
Condensed Consolidated Financial Statements Detail [Abstract]  
Accrued and Other Liabilities

Accrued and other liabilities consisted of the following (in thousands):

​

​

​

​

​

​

​

​

​

​

June 30, 

​

December 31, 

​

    

2021

    

2020

Accrued legal and accounting fees

​

$

454

​

$

351

Accrued incentive compensation

​

​

466

​

​

71

Accrued payroll and other

​

 

139

​

 

220

Total

​

$

1,059

​

$

642

​

Reconciliation of Numerator and Denominator Used in Calculation of Basic and Diluted Net (Loss) per Share Available to Common Stockholders

The following is a reconciliation of the numerator (net loss) and the denominator (number of shares) used in the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share amounts):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended June 30, 

​

Six Months Ended June 30, 

​

    

2021

    

2020

    

2021

    

2020

Numerator

 

​

  

 

​

  

 

​

  

 

​

  

Net loss

​

$

(2,237)

​

$

(3,533)

​

$

(9,610)

​

$

(8,291)

Less: Series A accumulated dividends

​

 

(530)

​

 

—

​

 

(1,061)

​

​

—

Less: Series B accumulated dividends

​

 

(763)

​

 

—

​

 

(763)

​

​

—

Net loss available to common stockholders, basic and diluted

​

$

(3,530)

​

$

(3,533)

​

$

(11,434)

​

$

(8,291)

​

​

 

​

​

​

​

​

​

​

​

 

​

Denominator

​

 

​

​

 

​

​

 

​

​

 

​

Weighted average shares used in computing basic and diluted net loss per share available to common stockholders

​

 

11,285

​

 

10,824

​

 

11,263

​

 

10,292

Basic and diluted net loss per share of common stock

​

$

(0.31)

​

$

(0.33)

​

$

(1.02)

​

$

(0.81)

​

Outstanding Securities Considered Anti-Dilutive

The following table shows the weighted-average outstanding securities considered anti-dilutive and therefore excluded from the computation of diluted net loss per share attributable to common stockholders (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended June 30, 

​

Six Months Ended June 30, 

​

    

2021

    

2020

    

2021

    

2020

Convertible preferred stock

​

5,003

​

5,196

​

5,003

​

5,726

Common stock options

 

377

 

564

 

318

​

578

Warrants for common stock

 

5

 

19

 

5

​

19

Total

 

5,385

 

5,779

 

5,326

 

6,323